NonREM Disorders of Arousal and Related Parasomnias: an Updated Review.

Parasomnia confusional arousal disorders of arousal parasomnia overlap disorder restless legs syndrome sexsomnia sleep terror sleepwalking somnambulism status dissociatus

Journal

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
ISSN: 1878-7479
Titre abrégé: Neurotherapeutics
Pays: United States
ID NLM: 101290381

Informations de publication

Date de publication:
01 2021
Historique:
accepted: 14 01 2021
pubmed: 3 2 2021
medline: 15 12 2021
entrez: 2 2 2021
Statut: ppublish

Résumé

Parasomnias are abnormal behaviors and/or experiences emanating from or associated with sleep typically manifesting as motor movements of varying semiology. We discuss mainly nonrapid eye movement sleep and related parasomnias in this article. Sleepwalking (SW), sleep terrors (ST), confusional arousals, and related disorders result from an incomplete dissociation of wakefulness from nonrapid eye movement (NREM) sleep. Conditions that provoke repeated cortical arousals, and/or promote sleep inertia, lead to NREM parasomnias by impairing normal arousal mechanisms. Changes in the cyclic alternating pattern, a biomarker of arousal instability in NREM sleep, are noted in sleepwalking disorders. Sleep-related eating disorder (SRED) is characterized by a disruption of the nocturnal fast with episodes of feeding after arousal from sleep. SRED is often associated with the use of sedative-hypnotic medications, in particular the widely prescribed benzodiazepine receptor agonists. Compelling evidence suggests that nocturnal eating may in some cases be another nonmotor manifestation of Restless Legs Syndrome (RLS). Initial management should focus upon decreasing the potential for sleep-related injury followed by treating comorbid sleep disorders and eliminating incriminating drugs. Sexsomnia is a subtype of disorders of arousal, where sexual behavior emerges from partial arousal from nonREM sleep. Overlap parasomnia disorders consist of abnormal sleep-related behavior both in nonREM and REM sleep. Status dissociatus is referred to as a breakdown of the sleep architecture where an admixture of various sleep state markers is seen without any specific demarcation. Benzodiazepine therapy can be effective in controlling SW, ST, and sexsomnia, but not SRED. Paroxetine has been reported to provide benefit in some cases of ST. Topiramate, pramipexole, and sertraline can be effective in SRED. Pharmacotherapy for other parasomnias continues to be less certain, necessitating further investigation. NREM parasomnias may resolve spontaneously but require a review of priming and predisposing factors.

Identifiants

pubmed: 33527254
doi: 10.1007/s13311-021-01011-y
pii: 10.1007/s13311-021-01011-y
pmc: PMC8116392
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

124-139

Références

American Academy of Sleep Medicine. International classification of sleep disorders. 3rd ed. Darien, IL. Am Acad Sleep Med. 2014;3 rd editi.
GUILLEMINAULT C, KIRISOGLU C, DAROSA A, LOPES C, CHAN A. Sleepwalking, a disorder of NREM sleep instability. Sleep Med. 2006;7(2):163-170. https://doi.org/10.1016/j.sleep.2005.12.006
doi: 10.1016/j.sleep.2005.12.006 pubmed: 16459139
Irfan M, Schenck CH. Sleep-related orgasms in a 57-year-old woman: A case report. J Clin Sleep Med. 2018;14(1). https://doi.org/10.5664/jcsm.6902
Dubessy A-L, Leu-Semenescu S, Attali V, Maranci J-B, Arnulf I. Sexsomnia: A Specialized Non-REM Parasomnia? Sleep. 2017;40(2). https://doi.org/10.1093/sleep/zsw043
Schenck CH, Arnulf I, Mahowald MW. Sleep and sex: what can go wrong? A review of the literature on sleep related disorders and abnormal sexual behaviors and experiences. Sleep. 2007;30(6):683-702. https://doi.org/10.1093/sleep/30.6.683
doi: 10.1093/sleep/30.6.683 pubmed: 17580590 pmcid: 1978350
Schenck CH. Update on Sexsomnia, Sleep Related Sexual Seizures, and Forensic Implications. NeuroQuantology. 2015;13(4). https://doi.org/10.14704/nq.2015.13.4.873
Muza R, Lawrence M, Drakatos P. The reality of sexsomnia. Curr Opin Pulm Med. 2016;22(6):576-582. https://doi.org/10.1097/MCP.0000000000000321
doi: 10.1097/MCP.0000000000000321 pubmed: 27607155
Howell MJ, Schenck CH. Restless nocturnal eating: a common feature of Willis-Ekbom Syndrome (RLS). J Clin Sleep Med. 2012;8(4):413-419. https://doi.org/10.5664/jcsm.2036
doi: 10.5664/jcsm.2036 pubmed: 22893772 pmcid: 3407260
EKBOM KA. Restless legs syndrome. Neurology. 1960;10:868-873. https://doi.org/10.1212/wnl.10.9.868
doi: 10.1212/wnl.10.9.868 pubmed: 13726241
Hublin C, Kaprio J, Partinen M, Heikkila K, Koskenvuo M. Prevalence and Genetics of Sleepwalking: A Population-based Twin Study. Neurology. 1997;48(1):177-181. https://doi.org/10.1212/WNL.48.1.177
doi: 10.1212/WNL.48.1.177 pubmed: 9008515
Dolder CR, Nelson MH. Hypnosedative-induced complex behaviours : incidence, mechanisms and management. CNS Drugs. 2008;22(12):1021-1036. https://doi.org/10.2165/0023210-200822120-00005
doi: 10.2165/0023210-200822120-00005 pubmed: 18998740
Espa F, Dauvilliers Y, Ondze B, Billiard M, Besset A. Arousal reactions in sleepwalking and night terrors in adults: the role of respiratory events. Sleep. 2002;25(8):871-875. http://www.ncbi.nlm.nih.gov/pubmed/12489893
doi: 10.1093/sleep/25.8.32
Szucs A, Horvath A, Anikó P. Progress in elucidating the pathophysiological basis of nonrapid eye movement parasomnias: not yet informing therapeutic strategies. Nat Sci Sleep. Published online March 2016:73. https://doi.org/10.2147/NSS.S71513
Pilon M, Montplaisir J, Zadra A. Precipitating factors of somnambulism: impact of sleep deprivation and forced arousals. Neurology. 2008;70(24):2284-2290. https://doi.org/10.1212/01.wnl.0000304082.49839.86
doi: 10.1212/01.wnl.0000304082.49839.86 pubmed: 18463368
Lam S-P, Fong SY-Y, Yu MW-M, Li SX, Wing Y-K. Sleepwalking in psychiatric patients: comparison of childhood and adult onset. Aust N Z J Psychiatry. 2009;43(5):426-430. https://doi.org/10.1080/00048670902817703
doi: 10.1080/00048670902817703 pubmed: 19373703
Morgenthaler TI, Silber MH. Amnestic sleep-related eating disorder associated with zolpidem. Sleep Med. 2002;3(4):323-327. https://doi.org/10.1016/s1389-9457(02)00007-2
doi: 10.1016/s1389-9457(02)00007-2 pubmed: 14592194
Liskow B, Pikalov A. Zaleplon overdose associated with sleepwalking and complex behavior. J Am Acad Child Adolesc Psychiatry. 2004;43(8):927-928. https://doi.org/10.1097/01.chi.0000129219.66563.aa
doi: 10.1097/01.chi.0000129219.66563.aa pubmed: 15266187
Wallace DM, Maze T, Shafazand S. Sodium oxybate-induced sleep driving and sleep-related eating disorder. J Clin Sleep Med. 2011;7(3):310-311. https://doi.org/10.5664/JCSM.1082
doi: 10.5664/JCSM.1082 pubmed: 21677903 pmcid: 3113972
Ferrándiz-Santos JA, Mataix-Sanjuan AL. Amitriptyline and somnambulism. Ann Pharmacother. 2000;34(10):1208. https://doi.org/10.1345/aph.10073
doi: 10.1345/aph.10073 pubmed: 11054994
Oulis P, Kokras N, Papadimitriou GN, Masdrakis VG. Bupropion-induced sleepwalking. J Clin Psychopharmacol. 2010;30(1):83-84. https://doi.org/10.1097/JCP.0b013e3181c9c8a2
doi: 10.1097/JCP.0b013e3181c9c8a2 pubmed: 20075658
Kawashima T, Yamada S. Paroxetine-induced somnambulism. J Clin Psychiatry. 2003;64(4):483. https://doi.org/10.4088/jcp.v64n0420e
doi: 10.4088/jcp.v64n0420e pubmed: 12716257
Yeh Y-W, Chen C-H, Feng H-M, Wang S-C, Kuo S-C, Chen C-K. New onset somnambulism associated with different dosage of mirtazapine: a case report. Clin Neuropharmacol. 32(4):232-233. https://doi.org/10.1097/WNF.0b013e318187bafc
Landry P, Warnes H, Nielsen T, Montplaisir J. Somnambulistic-like behaviour in patients attending a lithium clinic. Int Clin Psychopharmacol. 1999;14(3):173-175. http://www.ncbi.nlm.nih.gov/pubmed/10435770
doi: 10.1097/00004850-199905030-00004
Hafeez ZH, Kalinowski CM. Somnambulism induced by quetiapine: two case reports and a review of the literature. CNS Spectr. 2007;12(12):910-912. https://doi.org/10.1017/s1092852900015698
doi: 10.1017/s1092852900015698 pubmed: 18163036
Paquet V, Strul J, Servais L, Pelc I, Fossion P. Sleep-related eating disorder induced by olanzapine. J Clin Psychiatry. 2002;63(7):597. https://doi.org/10.4088/jcp.v63n0710d
doi: 10.4088/jcp.v63n0710d pubmed: 12143918
Chiu Y-H, Chen C-H, Shen WW. Somnambulism secondary to olanzapine treatment in one patient with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(2):581-582. https://doi.org/10.1016/j.pnpbp.2007.10.006
doi: 10.1016/j.pnpbp.2007.10.006 pubmed: 18006134
Hensel J, Pillmann F. Late-life somnambulism after therapy with metoprolol. Clin Neuropharmacol. 31(4):248-250. https://doi.org/10.1097/WNF.0b013e318157425a
Varkey BM, Varkey LM. Topiramate induced somnabulism and automatic behaviour. Indian J Med Sci. 2003;57(11):508-510. http://www.ncbi.nlm.nih.gov/pubmed/14646161
pubmed: 14646161
von Vigier RO, Vella S, Bianchetti MG. Agitated sleepwalking with fluoroquinolone therapy. Pediatr Infect Dis J. 1999;18(5):484-485. https://doi.org/10.1097/00006454-199905000-00024
doi: 10.1097/00006454-199905000-00024
Casez O, Dananchet Y, Besson G. Migraine and somnambulism. Neurology. 2005;65(8):1334-1335. https://doi.org/10.1212/01.wnl.0000180937.20774.20
doi: 10.1212/01.wnl.0000180937.20774.20 pubmed: 16247080
Kales JD, Kales A, Soldatos CR, Chamberlin K, Martin ED. Sleepwalking and night terrors related to febrile illness. Am J Psychiatry. 1979;136(9):1214-1215. https://doi.org/10.1176/ajp.136.9.1214
doi: 10.1176/ajp.136.9.1214 pubmed: 474819
Mouzas O, Angelopoulos N, Papaliagka M, Tsogas P. Increased frequency of self-reported parasomnias in patients suffering from vitiligo. Eur J Dermatol. 18(2):165-168. https://doi.org/10.1684/ejd.2008.0355
Erickson J, Vaughn B V. Non-REM Parasomnia: The Promise of Precision Medicine. Sleep Med Clin. 2019;14(3):363-370. https://doi.org/10.1016/j.jsmc.2019.05.002
doi: 10.1016/j.jsmc.2019.05.002 pubmed: 31375204
Parrino L, Halasz P, Tassinari CA, Terzano MG. CAP, epilepsy and motor events during sleep: the unifying role of arousal. Sleep Med Rev. 2006;10(4):267-285. https://doi.org/10.1016/j.smrv.2005.12.004
doi: 10.1016/j.smrv.2005.12.004 pubmed: 16809057
Steriade M, Llinás RR. The functional states of the thalamus and the associated neuronal interplay. Physiol Rev. 1988;68(3):649-742. https://doi.org/10.1152/physrev.1988.68.3.649
doi: 10.1152/physrev.1988.68.3.649 pubmed: 2839857
Neckelmann D, Ursin R. Sleep stages and EEG power spectrum in relation to acoustical stimulus arousal threshold in the rat. Sleep. 1993;16(5):467-477. http://www.ncbi.nlm.nih.gov/pubmed/8378687
pubmed: 8378687
Ohayon MM, Guilleminault C, Priest RG. Night terrors, sleepwalking, and confusional arousals in the general population: their frequency and relationship to other sleep and mental disorders. J Clin Psychiatry. 1999;60(4):268-276; quiz 277. https://doi.org/10.4088/jcp.v60n0413
doi: 10.4088/jcp.v60n0413 pubmed: 10221293
Mahowald MW, Schenck CH, Cramer Bornemann MA. Sleep-related violence. Curr Neurol Neurosci Rep. 2005;5(2):153-158. https://doi.org/10.1007/s11910-005-0014-3
doi: 10.1007/s11910-005-0014-3 pubmed: 15743554
Zucconi M, Oldani A, Ferini-Strambi L, Smirne S. Arousal fluctuations in non-rapid eye movement parasomnias: the role of cyclic alternating pattern as a measure of sleep instability. J Clin Neurophysiol. 1995;12(2):147-154. http://www.ncbi.nlm.nih.gov/pubmed/7797629
doi: 10.1097/00004691-199503000-00005
Schenck CH, Pareja JA, Patterson AL, Mahowald MW. Analysis of polysomnographic events surrounding 252 slow-wave sleep arousals in thirty-eight adults with injurious sleepwalking and sleep terrors. J Clin Neurophysiol. 1998;15(2):159-166. https://doi.org/10.1097/00004691-199803000-00010
doi: 10.1097/00004691-199803000-00010 pubmed: 9563584
Espa F, Ondze B, Deglise P, Billiard M, Besset A. Sleep architecture, slow wave activity, and sleep spindles in adult patients with sleepwalking and sleep terrors. Clin Neurophysiol. 2000;111(5):929-939. https://doi.org/10.1016/s1388-2457(00)00249-2
doi: 10.1016/s1388-2457(00)00249-2 pubmed: 10802466
Guilleminault C, Kirisoglu C, Bao G, Arias V, Chan A, Li KK. Adult chronic sleepwalking and its treatment based on polysomnography. Brain. 2005;128(Pt 5):1062-1069. https://doi.org/10.1093/brain/awh481
doi: 10.1093/brain/awh481 pubmed: 15817520
Busek P, Vankova J, Opavsky J, Salinger J, Stepanova I, Nevsimalova S. [Spectral analysis of the variations in heart rate and cardiac activation on waking up in sleepwalking]. Rev Neurol. 41(6):338-343. http://www.ncbi.nlm.nih.gov/pubmed/16163654
Gaudreau H, Joncas S, Zadra A, Montplaisir J. Dynamics of slow-wave activity during the NREM sleep of sleepwalkers and control subjects. Sleep. 2000;23(6):755-760. http://www.ncbi.nlm.nih.gov/pubmed/11007442
doi: 10.1093/sleep/23.6.1d
Guilleminault C, Poyares D, Aftab FA, Palombini L, Abat F. Sleep and wakefulness in somnambulism: a spectral analysis study. J Psychosom Res. 2001;51(2):411-416. https://doi.org/10.1016/s0022-3999(01)00187-8
doi: 10.1016/s0022-3999(01)00187-8 pubmed: 11516762
Guilleminault C. Hypersynchronous slow delta, cyclic alternating pattern and sleepwalking. Sleep. 2006;29(1):14-15. http://www.ncbi.nlm.nih.gov/pubmed/16453974
pubmed: 16453974
Zadra A, Pilon M, Joncas S, Rompré S, Montplaisir J. Analysis of postarousal EEG activity during somnambulistic episodes. J Sleep Res. 2004;13(3):279-284. https://doi.org/10.1111/j.1365-2869.2004.00404.x
doi: 10.1111/j.1365-2869.2004.00404.x pubmed: 15339264
Guilleminault C, Lee JH, Chan A, Lopes M-C, Huang Y, da Rosa A. Non-REM-sleep instability in recurrent sleepwalking in pre-pubertal children. Sleep Med. 2005;6(6):515-521. https://doi.org/10.1016/j.sleep.2005.03.003
doi: 10.1016/j.sleep.2005.03.003 pubmed: 15994122
Terzaghi M, Sartori I, Tassi L, et al. Evidence of dissociated arousal states during NREM parasomnia from an intracerebral neurophysiological study. Sleep. 2009;32(3):409-412. https://doi.org/10.1093/sleep/32.3.409
doi: 10.1093/sleep/32.3.409 pubmed: 19294961 pmcid: 2647795
Bassetti C, Vella S, Donati F, Wielepp P, Weder B. SPECT during sleepwalking. Lancet (London, England). 2000;356(9228):484-485. https://doi.org/10.1016/S0140-6736(00)02561-7
doi: 10.1016/S0140-6736(00)02561-7
Tassinari CA, Rubboli G, Gardella E, et al. Central pattern generators for a common semiology in fronto-limbic seizures and in parasomnias. A neuroethologic approach. Neurol Sci. 2005;26 Suppl 3:s225-32. https://doi.org/10.1007/s10072-005-0492-8
doi: 10.1007/s10072-005-0492-8 pubmed: 16331401
Tassinari CA, Cantalupo G, Högl B, et al. Neuroethological approach to frontolimbic epileptic seizures and parasomnias: The same central pattern generators for the same behaviours. Rev Neurol (Paris). 2009;165(10):762-768. https://doi.org/10.1016/j.neurol.2009.08.002
doi: 10.1016/j.neurol.2009.08.002 pubmed: 19733874
Braun AR, Balkin TJ, Wesenten NJ, et al. Regional cerebral blood flow throughout the sleep-wake cycle. An H2(15)O PET study. Brain. 1997;120 (Pt 7):1173-1197. https://doi.org/10.1093/brain/120.7.1173
doi: 10.1093/brain/120.7.1173 pubmed: 9236630
Juszczak GR, Swiergiel AH. Serotonergic hypothesis of sleepwalking. Med Hypotheses. 2005;64(1):28-32. https://doi.org/10.1016/j.mehy.2004.06.013
doi: 10.1016/j.mehy.2004.06.013 pubmed: 15533605
Wilson SJ, Lillywhite AR, Potokar JP, Bell CJ, Nutt DJ. Adult night terrors and paroxetine. Lancet (London, England). 1997;350(9072):185. https://doi.org/10.1016/s0140-6736(05)62351-3
doi: 10.1016/s0140-6736(05)62351-3
Vetrugno R, Manconi M, Ferini-Strambi L, Provini F, Plazzi G, Montagna P. Nocturnal eating: Sleep-related eating disorder or night eating syndrome? A videopolysomnographic study. Sleep. 2006;29(7):949-954. https://doi.org/10.1093/sleep/29.7.949
doi: 10.1093/sleep/29.7.949 pubmed: 16895263
Jacobs BL, Martín-Cora FJ, Fornal CA. Activity of medullary serotonergic neurons in freely moving animals. Brain Res Brain Res Rev. 2002;40(1-3):45-52. https://doi.org/10.1016/s0165-0173(02)00187-x
doi: 10.1016/s0165-0173(02)00187-x pubmed: 12589905
Schenck, Carlos H. Zolpidem-induced sleep-related eating disorder (SRED) in 19 patients. Sleep. 2005;28.
Ho T, Jimenez A, Sanchez I, Seeger C, Joseph M. Sleep-Related Eating Disorder Associated with Zolpidem: Cases Compiled From a Literature Review. Sleep Med X. Published online July 2020:100019. https://doi.org/10.1016/j.sleepx.2020.100019
Winkelman JW, Herzog DB, Fava M. The prevalence of sleep-related eating disorder in psychiatric and non-psychiatric populations. Psychol Med. 1999;29(6):1461-1466. https://doi.org/10.1017/s0033291799008272
doi: 10.1017/s0033291799008272 pubmed: 10616953
Vetrugno R, Manconi M, Ferini-Strambi L, Provini F, Plazzi G, Montagna P. Nocturnal Eating: Sleep-Related Eating Disorder or Night Eating Syndrome? A Videopolysomnographic Study. Sleep. 2006;29(7):949-954. https://doi.org/10.1093/sleep/29.7.949
doi: 10.1093/sleep/29.7.949 pubmed: 16895263
Schenck CH, Hurwitz TD, Bundlie SR, Mahowald MW. Sleep-related eating disorders: polysomnographic correlates of a heterogeneous syndrome distinct from daytime eating disorders. Sleep. 1991;14(5):419-431. https://doi.org/10.1093/sleep/14.5.419
doi: 10.1093/sleep/14.5.419 pubmed: 1759095
Reading D. Paradox lost: midnight in the battleground of sleep and dreams. J Neurol Neurosurg Psychiatry. 2006;77(12):1387-1387. https://doi.org/10.1136/jnnp.2006.096131
doi: 10.1136/jnnp.2006.096131 pmcid: 2077413
Nadel C. Somnambulism, Bed-Time Medication and Over-Eating. Br J Psychiatry. 1981;139(1):79-79. https://doi.org/10.1192/bjp.139.1.79a
doi: 10.1192/bjp.139.1.79a pubmed: 6117349
Güneş S, Camkurt MA. Sleep-Related Eating Disorder Associated With Risperidone. J Clin Psychopharmacol. 2016;36(3):286-288. https://doi.org/10.1097/JCP.0000000000000502
doi: 10.1097/JCP.0000000000000502 pubmed: 27035493
Molina SM, Joshi KG. A case of zaleplon-induced amnestic sleep-related eating disorder. J Clin Psychiatry. 2010;71(2):210-211. https://doi.org/10.4088/JCP.09l05364bro
doi: 10.4088/JCP.09l05364bro pubmed: 20193650
Chiang A, Krystal A. Report of two cases where sleep related eating behavior occurred with the extended-release formulation but not the immediate-release formulation of a sedative-hypnotic agent. J Clin Sleep Med. 2008;4(2):155-156. http://www.ncbi.nlm.nih.gov/pubmed/18468314
doi: 10.5664/jcsm.27132
Wing YK, Lam SP, Li SX, Zhang J, Yu MWM. Sleep-related eating disorder and zolpidem: an open interventional cohort study. J Clin Psychiatry. 2010;71(5):653-656. https://doi.org/10.4088/JCP.09l05623gry
doi: 10.4088/JCP.09l05623gry pubmed: 20492858
Hwang T-J, Ni H-C, Chen H-C, Lin Y-T, Liao S-C. Risk predictors for hypnosedative-related complex sleep behaviors: a retrospective, cross-sectional pilot study. J Clin Psychiatry. 2010;71(10):1331-1335. https://doi.org/10.4088/JCP.09m05083bro
doi: 10.4088/JCP.09m05083bro pubmed: 20441722
Provini F, Antelmi E, Vignatelli L, et al. Association of restless legs syndrome with nocturnal eating: a case-control study. Mov Disord. 2009;24(6):871-877. https://doi.org/10.1002/mds.22460
doi: 10.1002/mds.22460 pubmed: 19199358
Rodriguez CL, Foldvary-Schaefer N. Clinical neurophysiology of NREM parasomnias. Handb Clin Neurol. 2019;161:397-410. https://doi.org/10.1016/B978-0-444-64142-7.00063-1
doi: 10.1016/B978-0-444-64142-7.00063-1 pubmed: 31307616
Ekbom KA. Restless legs syndrome. Neurology. 1960;10(9):868-868. https://doi.org/10.1212/WNL.10.9.868
doi: 10.1212/WNL.10.9.868 pubmed: 13726241
Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med. 2004;164(2):196-202. https://doi.org/10.1001/archinte.164.2.196
doi: 10.1001/archinte.164.2.196 pubmed: 14744844
Allen RP, Walters AS, Montplaisir J, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med. 2005;165(11):1286-1292. https://doi.org/10.1001/archinte.165.11.1286
doi: 10.1001/archinte.165.11.1286 pubmed: 15956009
Paulus W, Dowling P, Rijsman R, Stiasny-Kolster K, Trenkwalder C. Update of the pathophysiology of the restless-legs-syndrome. Mov Disord. 2007;22 Suppl 1:S431-9. https://doi.org/10.1002/mds.21824
doi: 10.1002/mds.21824 pubmed: 18081164
Lavigne GJ, Kato T, Kolta A, Sessle BJ. Neurobiological mechanisms involved in sleep bruxism. Crit Rev Oral Biol Med. 2003;14(1):30-46. https://doi.org/10.1177/154411130301400104
doi: 10.1177/154411130301400104 pubmed: 12764018
Walters AS. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord. 1995;10(5):634-642. https://doi.org/10.1002/mds.870100517
doi: 10.1002/mds.870100517 pubmed: 8552117
Provini F, Antelmi E, Vignatelli L, et al. Increased prevalence of nocturnal smoking in restless legs syndrome (RLS). Sleep Med. 2010;11(2):218-220. https://doi.org/10.1016/j.sleep.2009.05.016
doi: 10.1016/j.sleep.2009.05.016 pubmed: 20064746
Driver-Dunckley ED, Noble BN, Hentz JG, et al. Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome. Clin Neuropharmacol. 30(5):249-255. https://doi.org/10.1097/wnf.0b013e31804c780e
Tippmann-Peikert M, Park JG, Boeve BF, Shepard JW, Silber MH. Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists. Neurology. 2007;68(4):301-303. https://doi.org/10.1212/01.wnl.0000252368.25106.b6
doi: 10.1212/01.wnl.0000252368.25106.b6 pubmed: 17242339
Nirenberg MJ, Waters C. Nocturnal eating in restless legs syndrome. Mov Disord. 2010;25(1):126-127. https://doi.org/10.1002/mds.22797
doi: 10.1002/mds.22797 pubmed: 19795475
Martin-Iverson MT, Dourish CT. Role of dopamine D-1 and D-2 receptor subtypes in mediating dopamine agonist effects on food consumption in rats. Psychopharmacology (Berl). 1988;96(3):370-374. https://doi.org/10.1007/BF00216064
doi: 10.1007/BF00216064 pubmed: 2906154
Schenck CH, Mahowald MW. Combined bupropion-levodopa-trazodone therapy of sleep-related eating and sleep disruption in two adults with chemical dependency. Sleep. 2000;23(5):587-588. http://www.ncbi.nlm.nih.gov/pubmed/10947025
pubmed: 10947025
Provini F, Albani F, Vetrugno R, et al. A pilot double-blind placebo-controlled trial of low-dose pramipexole in sleep-related eating disorder. Eur J Neurol. 2005;12(6):432-436. https://doi.org/10.1111/j.1468-1331.2005.01017.x
doi: 10.1111/j.1468-1331.2005.01017.x pubmed: 15885046
Nzwalo H, Ferreira L, Peralta R, Bentes C. Sleep-related eating disorder secondary to zolpidem. BMJ Case Rep. 2013;2013. https://doi.org/10.1136/bcr-2012-008003
Holm KJ, Goa KL. Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Drugs. 2000;59(4):865-889. https://doi.org/10.2165/00003495-200059040-00014
doi: 10.2165/00003495-200059040-00014 pubmed: 10804040
Wills L, Garcia J. Parasomnias: epidemiology and management. CNS Drugs. 2002;16(12):803-810. https://doi.org/10.2165/00023210-200216120-00002
doi: 10.2165/00023210-200216120-00002 pubmed: 12421114
Schenck CH, Milner DM, Hurwitz TD, Bundlie SR, Mahowald MW. A polysomnographic and clinical report on sleep-related injury in 100 adult patients. Am J Psychiatry. 1989;146(9):1166-1173. https://doi.org/10.1176/ajp.146.9.1166
doi: 10.1176/ajp.146.9.1166 pubmed: 2764174
Drakatos P, Marples L, Muza R, et al. Video polysomnographic findings in non-rapid eye movement parasomnia. J Sleep Res. 2019;28(2):e12772. https://doi.org/10.1111/jsr.12772
doi: 10.1111/jsr.12772 pubmed: 30295353
Irfan M, Schenck CH, Howell MJ. Non-rapid eye movement sleep and overlap parasomnias. Contin Lifelong Learn Neurol. 2017;23(4, SleepNeurology). https://doi.org/10.1212/CON.0000000000000503
Zucconi M, Galbiati A, Rinaldi F, Casoni F, Ferini-Strambi L. An update on the treatment of Restless Legs Syndrome/Willis-Ekbom Disease: prospects and challenges. Expert Rev Neurother. 2018;18(9):705-713. https://doi.org/10.1080/14737175.2018.1510773
doi: 10.1080/14737175.2018.1510773 pubmed: 30095315
Smolensky MH, Hermida RC, Reinberg A, Sackett-Lundeen L, Portaluppi F. Circadian disruption: New clinical perspective of disease pathology and basis for chronotherapeutic intervention. Chronobiol Int. 2016;33(8):1101-1119. https://doi.org/10.1080/07420528.2016.1184678
doi: 10.1080/07420528.2016.1184678 pubmed: 27308960
Drakatos P, Marples L, Muza R, et al. NREM parasomnias: a treatment approach based upon a retrospective case series of 512 patients. Sleep Med. 2019;53:181-188. https://doi.org/10.1016/j.sleep.2018.03.021
doi: 10.1016/j.sleep.2018.03.021 pubmed: 29753639 pmcid: 6558250
Sivertsen B, Omvik S, Pallesen S, et al. Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial. JAMA. 2006;295(24):2851-2858. https://doi.org/10.1001/jama.295.24.2851
doi: 10.1001/jama.295.24.2851 pubmed: 16804151
Galbiati A, Rinaldi F, Giora E, Ferini-Strambi L, Marelli S. Behavioural and Cognitive-Behavioural Treatments of Parasomnias. Behav Neurol. 2015;2015. https://doi.org/10.1155/2015/786928
Schenck CH, Mahowald MW. Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. Am J Med. 1996;100(3):333-337. https://doi.org/10.1016/S0002-9343(97)89493-4
doi: 10.1016/S0002-9343(97)89493-4 pubmed: 8629680
Balon R. Sleep terror disorder and insomnia treated with trazodone: a case report. Ann Clin Psychiatry. 1994;6(3):161-163. https://doi.org/10.3109/10401239409148998
doi: 10.3109/10401239409148998 pubmed: 7881496
Varghese R, Rey de Castro J, Liendo C, Schenck CH. Two Cases of Sleep-Related Eating Disorder Responding Promptly to Low-Dose Sertraline Therapy. J Clin Sleep Med. 2018;14(10):1805-1808. https://doi.org/10.5664/jcsm.7404
doi: 10.5664/jcsm.7404 pubmed: 30353815 pmcid: 6175812
Winkelman JW, Wipper B, Purks J, Mei L, Schoerning L. Topiramate reduces nocturnal eating in sleep-related eating disorder. Sleep. 2020;43(9). https://doi.org/10.1093/sleep/zsaa060
Hurwitz TD, Mahowald MW, Schenck CH, Schluter JL, Bundlie SR. A retrospective outcome study and review of hypnosis as treatment of adults with sleepwalking and sleep terror. J Nerv Ment Dis. 1991;179(4):228-233. https://doi.org/10.1097/00005053-199104000-00009
doi: 10.1097/00005053-199104000-00009 pubmed: 2007894
Hauri PJ, Silber MH, Boeve BF. The treatment of parasomnias with hypnosis: a 5-year follow-up study. J Clin Sleep Med. 2007;3(4):369-373. http://www.ncbi.nlm.nih.gov/pubmed/17694725
doi: 10.5664/jcsm.26858
Byars KC, Simon SL. American Academy of Pediatrics 2016 Safe Sleep Practices: Implications for Pediatric Behavioral Sleep Medicine. Behav Sleep Med. 2017;15(3):175-179. https://doi.org/10.1080/15402002.2017.1292726
doi: 10.1080/15402002.2017.1292726 pubmed: 28296540
Ntafouli M, Galbiati A, Gazea M, Bassetti CLA, Bargiotas P. Update on nonpharmacological interventions in parasomnias. Postgrad Med. 2020;132(1):72-79. https://doi.org/10.1080/00325481.2019.1697119
doi: 10.1080/00325481.2019.1697119 pubmed: 31760836
Harris M, Grunstein RR. Treatments for somnambulism in adults: assessing the evidence. Sleep Med Rev. 2009;13(4):295-297. https://doi.org/10.1016/j.smrv.2008.09.003
doi: 10.1016/j.smrv.2008.09.003 pubmed: 19046651
Kavey NB, Whyte J, Resor SR, Gidro-Frank S. Somnambulism in adults. Neurology. 1990;40(5):749-749. https://doi.org/10.1212/WNL.40.5.749
doi: 10.1212/WNL.40.5.749 pubmed: 2330099
Schenck CH, Mahowald MW. Review of nocturnal sleep-related eating disorders. Int J Eat Disord. 1994;15(4):343-356. https://doi.org/10.1002/eat.2260150405
doi: 10.1002/eat.2260150405 pubmed: 8032349
Schenck CH, Hurwitz TD, O’Connor KA, Mahowald MW. Additional categories of sleep-related eating disorders and the current status of treatment. Sleep. 1993;16(5):457-466. http://www.ncbi.nlm.nih.gov/pubmed/8104356
pubmed: 8104356
Winkelman JW. Treatment of nocturnal eating syndrome and sleep-related eating disorder with topiramate. Sleep Med. 2003;4(3):243-246. https://doi.org/10.1016/s1389-9457(03)00060-1
doi: 10.1016/s1389-9457(03)00060-1 pubmed: 14592329
Winkelman JW. Efficacy and tolerability of open-label topiramate in the treatment of sleep-related eating disorder: a retrospective case series. J Clin Psychiatry. 2006;67(11):1729-1734. https://doi.org/10.4088/jcp.v67n1109
doi: 10.4088/jcp.v67n1109 pubmed: 17196052
Varghese R, Rey de Castro J, Liendo C, Schenck CH. Two Cases of Sleep-Related Eating Disorder Responding Promptly to Low-Dose Sertraline Therapy. J Clin Sleep Med. 2018;14(10):1805-1808. https://doi.org/10.5664/jcsm.7404
doi: 10.5664/jcsm.7404 pubmed: 30353815 pmcid: 6175812
Matos N, Iranzo A, Gaig C, Santamaria J. Video-polysomnographic documentation of non-rapid eye movement sleep parasomnia followed by rapid eye movement sleep behavior disorder: a parasomnia overlap disorder? Sleep Med. 2016;23:46-48. https://doi.org/10.1016/j.sleep.2016.04.017
doi: 10.1016/j.sleep.2016.04.017 pubmed: 27692275
Dumitrascu O, Schenck CH, Applebee G, Attarian H. Parasomnia overlap disorder: a distinct pathophysiologic entity or a variant of rapid eye movement sleep behavior disorder? A case series. Sleep Med. 2013;14(11):1217-1220. https://doi.org/10.1016/j.sleep.2013.06.012
doi: 10.1016/j.sleep.2013.06.012 pubmed: 24051111
Mahowald MW, Schenck CH. Status dissociatus--a perspective on states of being. Sleep. 1991;14(1):69-79. https://doi.org/10.1093/sleep/14.1.69
doi: 10.1093/sleep/14.1.69 pubmed: 1811323
Miró-Andreu A, López-Bernabé R, Garnés Sánchez MC, Maeztu Sardiña MC. Status dissociatus: The most extreme expression of state dissociation. Neurologia. 2019;34(3):209-211. https://doi.org/10.1016/j.nrl.2017.05.004
doi: 10.1016/j.nrl.2017.05.004 pubmed: 28712838
Antelmi E, Ferri R, Iranzo A, et al. From state dissociation to status dissociatus. Sleep Med Rev. 2016;28:5-17. https://doi.org/10.1016/j.smrv.2015.07.003
doi: 10.1016/j.smrv.2015.07.003 pubmed: 26431902

Auteurs

Muna Irfan (M)

Department of Neurology, Minneapolis Veterans Affairs Medical Center/ Pulmonary allergy, Critical Care and Sleep, University of Minnesota, Minneapolis, MN, USA. irfan007@umn.edu.

Carlos H Schenck (CH)

Department of Psychiatry, Hennepin Health Care, University of Minnesota, Minneapolis, MN, USA.

Michael J Howell (MJ)

Department of Neurology, Sleep Disorders Center, University of Minnesota Medical Center, Minneapolis, MN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH